Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: still waiting news.... Possible.....

I think an interesting question for the shareholder meeting with be:



1. Have the Nupower IPs passed the "validation stage" with the target customers:

From - June 17 PR on NUpower



"Patriot announced the phase one, “validation phase” agreement, whereby both companies will work exclusively together to commercialize NuPOWER’s extensive portfolio consisting of more than 60 claims covered under four issued and allowed patents."

also

T"his initial “validation phase” agreement will focus the two companies on a handful of target customers before proceeding to a broader, full commercialization phase agreement."



2. What are the expected or target revenues for licensing this IP with Nupower.



PTSC being PTSC.... not sure we will get any specific answers....

Share
New Message
Please login to post a reply